A kind of colorectal cancer screening kit
A kit and colorectal cancer technology, applied in instruments, biochemical equipment and methods, analytical materials, etc., can solve the problems of high cost, large number of detection genes, low sensitivity and specificity, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0117] Example 1 Sample Collection
[0118] After informed consent, peripheral blood samples were collected from 187 colorectal cancer patients (CRC) confirmed by clinicopathological diagnosis and 173 colonoscopy-negative control patients (CNC) between 2006 and 2010.
[0119] CRC was recruited from the Department of Colorectal Surgery, Shanghai Cancer Center, Fudan University, China, and all patients were staged according to the TNM staging system recommended by the International Union Against Cancer (UICC). None of the patients received preoperative chemotherapy or radiotherapy. Patients with hereditary colorectal cancer or inflammatory bowel disease (Corhn's disease or ulcerative colitis) were excluded from the present invention. CNCs were recruited from Shanghai Community Hospital and passed colonoscopy without any symptoms of colorectal cancer or polyps. The demographic and clinical characteristics of the test samples are shown in Table 1:
[0120] Table 1 Characteristi...
Embodiment 2
[0126] Example 2 Detection of expression levels of 18 genes such as DUSP2
[0127] 1. Experimental method
[0128] (1) Selection of housekeeping genes
[0129] The geometric mean of the expression levels of CSNK1G2, DECR1, and FARP1 was used as the "meta-housekeeping gene" as a correction factor for real-time quantitative PCR data.
[0130] (2) RNA extraction and real-time quantitative PCR detection
[0131] Whole blood draw: Take 2.5ml of peripheral blood from each participant in PAXgene TM Blood RNA tubes (PreAnalytix GmbH, Hombrechtikon, CH), and processed according to the instructions;
[0132] Total RNA extraction: according to the instructions, use PAXgene TM Blood RNA system (PreAnalytix) was used to extract total RNA; the amount of total RNA was detected with a spectrophotometer at an OD value of 260nm, and the RNA6000Nano on an Agilent bioanalyzer Kit (Agilent Technologies, Palo Alto, CA, U.S.A.) was used to detect the quality of total RNA, and the RNA with inte...
Embodiment 3
[0201] Example 3 Correlation between gene expression and colorectal cancer
[0202] 1. Correlation between single gene expression and colorectal cancer
[0203] Detect the expression levels of 18 genes in the blood samples of the 200 participants (wherein 100 CRCs, 100 CNCs) of group 1 in the embodiment 1 respectively according to the method of embodiment 2-relative expression, T test and calculate the control group The ROC curve was established based on the average relative expression level of the tumor group, and the area under the curve (AUC) of the ROC curve was calculated. AUC can reflect the correlation between the gene and colorectal cancer.
[0204] (1) DUSP2 (dual specificity phosphatase 2):
[0205]
[0206] The correlation between the expression level of DUSP2 gene and colorectal cancer is 0.75, and the average expression level difference between the control group and the tumor group is significant, P<0.01, low expression of this gene can significantly increase ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com